Monopar Therapeutics (MNPR) said Wednesday it closed its best efforts public offering of common shares at $16.25 per share for total gross proceeds of about $19.2 million.
The company said it plans to use proceeds for general corporate purposes.
Monopar Therapeutics shares were down more than 6% in recent trading.
Price: 15.19, Change: -1.02, Percent Change: -6.29
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。